Viewpoint Molecular Targeting won $10,000 in a competition held in September at the Iowa SBIR Showcase (Virtual SBIR Road Tour). Viewpoint Molecular Targeting, LLC develops pharmaceutical drugs for diagnostic imaging and therapy for cancer, with a focus on metastatic melanoma. The Iowa SBIR Showcase is part of a national outreach effort to convey the technology funding opportunity provided through the Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) programs. The SBIR/STTR programs annually provide $2.5 billion in funding to small advanced technology firms to spur new technological discoveries and facilitate the commercialization of innovations.
Viewpoint Molecular Targeting is a UIVentures supported starup based on University of Iowa research.
For additionmal information of this ventures see: VMT's Profile